Autoimmunity

Sylviane Muller has received her Doctoral degrees in Molecular Biology (1978) and Science (1984) from the University of Strasbourg, France. She has worked

as a Post-doctoral Fellow at the Max-Planck Institute for Immunobiology in Freiburg, Germany. She is currently a Distinguished class Research Director at the

CNRS and Professor at the Institute of Advanced Studies of the Strasbourg University (Chair Therapeutic Immunology). She is a Deputy Director of the Molecular

and Cellular Biology Institute, Director of the CNRS Unit Immunopathology and Therapeutic Chemistry and Head of the Drug Discovery Center for Cancer and

Inflammation. Medal is awarded 'Laboratory of Excellence’. Her research interests focus on molecular and cellular events involved in autoimmunity, especially in

the lupus disease. She has discovered the P140/Lupuzor peptide that is currently evaluated in a phase III clinical trial for lupus. She is the co-author of over 345

publications, Co-Inventor of ~30 patents and Co-Founder of NeoMPS (1986) and ImmuPharma (2002) companies. She has received the CNRS Silver Medal (2009)

and the CNRS Innovation Award (2015). Her research interests include molecular and cellular events involved in autoimmunity, especially in the lupus disease.